Key points are not available for this paper at this time.
Background: -linked chronic mucocutaneous candidiasis disease (CMCD). The diagnosis of CMCD and HIES relies on clinical features and molecular genetics. Objective: 17% in patients suspected of HIES or CMCD. Methods: 17% (<0.4%). Sufficient clinical and molecular data were available for 52 patients. Clinical data, molecular genetic results, and National Institutes of Health-HIES scores were analyzed. Results: = .0622) were associated with a diagnosis of HIES. Conclusions: 17 measurement is a valuable screening tool for excluding patients with P/LP variants in these genes, molecular genetics remains essential for a definitive diagnosis.
Molnár et al. (Sun,) studied this question.